Literature DB >> 12523913

Demystifying idiopathic interstitial pneumonia.

Harold R Collard1, Talmadge E King.   

Abstract

Careful histopathological evaluation has shown the traditionally clinical diagnosis of idiopathic interstitial pneumonia to be more heterogeneous than once thought. Its subclassification, based on clinicopathological criteria, has important therapeutic and prognostic implications. The most important distinction is the presence of usual interstitial pneumonia, the histopathological pattern seen in idiopathic pulmonary fibrosis. Idiopathic pulmonary fibrosis has a worse response to therapy and prognosis. New insight into the pathophysiology of idiopathic pulmonary fibrosis suggests a distinctly fibroproliferative process, and antifibrotic therapies show promise. Although the clinical and radiographic diagnosis of idiopathic pulmonary fibrosis can be made confidently in some cases, many patients require surgical lung biopsy to determine their underlying histopathological pattern. A structured, clinicopathological approach to the diagnosis of idiopathic interstitial pneumonia, with particular attention to the identification of idiopathic pulmonary fibrosis, ensures proper therapy, enhances prognosis, and allows for further investigation of therapies aimed at the distinct pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12523913     DOI: 10.1001/archinte.163.1.17

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  12 in total

1.  Diffuse interstitial lung disease: overlaps and uncertainties.

Authors:  Simon L F Walsh; David M Hansell
Journal:  Eur Radiol       Date:  2010-03-04       Impact factor: 5.315

Review 2.  Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.

Authors:  Talmadge E King
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

3.  Phosphorylation of the glucocorticoid receptor alters SMAD signaling in vocal fold fibroblasts.

Authors:  Shigeyuki Mukudai; Nao Hiwatashi; Renjie Bing; Michael Garabedian; Ryan C Branski
Journal:  Laryngoscope       Date:  2018-10-16       Impact factor: 3.325

Review 4.  Dendritic Cell Trafficking and Function in Rare Lung Diseases.

Authors:  Huan Liu; Claudia Jakubzick; Andrew R Osterburg; Rebecca L Nelson; Nishant Gupta; Francis X McCormack; Michael T Borchers
Journal:  Am J Respir Cell Mol Biol       Date:  2017-10       Impact factor: 6.914

5.  Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.

Authors:  S L Schmidt; A M Nambiar; N Tayob; B Sundaram; M K Han; B H Gross; E A Kazerooni; A R Chughtai; A Lagstein; J L Myers; S Murray; G B Toews; F J Martinez; K R Flaherty
Journal:  Eur Respir J       Date:  2010-12-09       Impact factor: 16.671

6.  Usual interstitial pneumonia associated with cytomegalovirus infection after percutaneous transluminal coronary angioplasty.

Authors:  M Rizos; M E Falagas; S Tsiodras; A Betsou; P Foukas; A Michalopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-08       Impact factor: 3.267

7.  Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia.

Authors:  Aryeh Fischer; Jeffrey J Swigris; Roland M du Bois; David A Lynch; Gregory P Downey; Gregory P Cosgrove; Stephen K Frankel; Evans R Fernandez-Perez; JoAnn Z Gillis; Kevin K Brown
Journal:  Respir Med       Date:  2009-06-03       Impact factor: 3.415

8.  Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease.

Authors:  Aryeh Fischer; Jeffrey J Swigris; Roland M du Bois; Steve D Groshong; Carlyne D Cool; Hakan Sahin; David A Lynch; JoAnn Z Gillis; Marc D Cohen; Richard T Meehan; Kevin K Brown
Journal:  Chest       Date:  2009-05-08       Impact factor: 9.410

9.  A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis.

Authors:  Judson M Englert; Lana E Hanford; Naftali Kaminski; Jacob M Tobolewski; Roderick J Tan; Cheryl L Fattman; Lasse Ramsgaard; Thomas J Richards; Inna Loutaev; Peter P Nawroth; Michael Kasper; Angelika Bierhaus; Tim D Oury
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

Review 10.  Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

Authors:  Argyris Tzouvelekis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2006-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.